Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) – Global Forecast to 2018:Life Sciences Market Research Reports

Life Sciences Market Research Reports

How to Get into Medical School A tested blueprint to approach the daunting admissions process with both confidence and success! Enroll in this online course for just $29. From our sponsors

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) – Global Forecast to 2018 Nov 18th 2013, 00:00, by vyankatesh The global is estimated to reach $2.0 billion by 2018 at a CAGR of more than 20% between 2013 and 2018. The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormone; whereas the recombinant glycosylated proteins market is further broken down into erythropoietin, monoclonal antibodies, and follitropin. Calcitonin and glucagon are considered in the recombinant peptides market. The recombinant glycosylated proteins segment is expected to witness the highest growth due to the increased demand for … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=130963. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/biosimilars-market-product-recombinant-non-glycosylated-proteins-insulin-filgrastim-somatropin-glycosylated-monoclonal-antibodies-erythropoietin-peptides-glucagon-calcitonin-applicatio-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions